Mary Prieve - PhaseRx Vice President - Biology
| PZRXQDelisted Stock | USD 0.0002 0.00 0.00% |
President
Dr. Mary G. Prieve, Ph.D., is Vice President Biology of the Company. Dr. Prieve joined PhaseRx in February 2008 as director of biology. Dr. Prieve leads the biology and formulation teams to develop polymer based nanoparticles for the delivery of siRNA and mRNA to target tissues of interest since 2015.
| Tenure | 9 years |
| Professional Marks | Ph.D |
| Phone | 206 805 6300 |
| Web | https://www.phaserx.com |
PhaseRx Management Efficiency
The company has return on total asset (ROA) of (0.642) % which means that it has lost $0.642 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.2817) %, meaning that it generated substantial loss on money invested by shareholders. PhaseRx's management efficiency ratios could be used to measure how well PhaseRx manages its routine affairs as well as how well it operates its assets and liabilities.PhaseRx has accumulated 5.13 M in total debt. PhaseRx has a current ratio of 2.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist PhaseRx until it has trouble settling it off, either with new capital or with free cash flow. So, PhaseRx's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PhaseRx sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PhaseRx to invest in growth at high rates of return. When we think about PhaseRx's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 1 records | PRESIDENT Age | ||
| Hubert MD | Forte Biosciences | 55 | |
Management Performance
| Return On Equity | -2.28 | ||||
| Return On Asset | -0.64 |
PhaseRx Leadership Team
Elected by the shareholders, the PhaseRx's board of directors comprises two types of representatives: PhaseRx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PhaseRx. The board's role is to monitor PhaseRx's management team and ensure that shareholders' interests are well served. PhaseRx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PhaseRx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Prof Hoffman, CoFounder | ||
| Mary Prieve, Vice President - Biology | ||
| Paul Johnson, CoFounder Director | ||
| Spencer Lemons, Head Devel | ||
| Robert Overell, President CEO, Principal Accounting Officer, Secretary, Director | ||
| Patrick Stayton, CoFounder |
PhaseRx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is PhaseRx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.28 | ||||
| Return On Asset | -0.64 | ||||
| Current Valuation | 199.2 K | ||||
| Shares Outstanding | 11.69 M | ||||
| Number Of Shares Shorted | 168.63 K | ||||
| Price To Book | 3.25 X | ||||
| EBITDA | (12.96 M) | ||||
| Net Income | (20.14 M) | ||||
| Cash And Equivalents | 5.26 M | ||||
| Cash Per Share | 0.45 X |
Pair Trading with PhaseRx
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PhaseRx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PhaseRx will appreciate offsetting losses from the drop in the long position's value.Moving against PhaseRx Pink Sheet
The ability to find closely correlated positions to PhaseRx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PhaseRx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PhaseRx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PhaseRx to buy it.
The correlation of PhaseRx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PhaseRx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PhaseRx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PhaseRx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in PhaseRx Pink Sheet
If you are still planning to invest in PhaseRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseRx's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |